Splicing-mediated antigen escape from immunotherapy for B-cell malignancies Editorial


Authors: Bourcier, J.; Abdel-Wahab, O.
Title: Splicing-mediated antigen escape from immunotherapy for B-cell malignancies
Abstract: In this issue of Blood Cancer Discovery, Zheng and colleagues identify that alternative RNA splicing of CD22 within B-cell acute lymphoblastic leukemia can result in antigen escape from CD22-targeted immunotherapies. Drug-resistant isoforms of CD22 exist within leukemic cells pretreatment and can influence response to the CD22-directed antibody-drug conjugate inotuzumab ozogamicin, the immunotoxin moxetumomab pasudotox, as well as anti-CD22 chimeric antigen receptor T cells.
Journal Title: Blood Cancer Discovery
Volume: 3
Issue: 2
ISSN: 2643-3230
Publisher: American Association for Cancer Research  
Date Published: 2022-03-01
Start Page: 87
End Page: 89
Language: English
ACCESSION: WOS:000767279000001
DOI: 10.1158/2643-3230.Bcd-21-0200
PROVIDER: wos
PUBMED: 35015686
Notes: Editorial Material -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors